WOLVERINE TRADING, LLC - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2021$168,000
-41.7%
41,595
-42.0%
0.00%
Q4 2020$288,000
+68.4%
71,667
+13.6%
0.00%
Q3 2020$171,000
+0.6%
63,066
-0.3%
0.00%
Q2 2020$170,000
-6.1%
63,236
-20.5%
0.00%
Q1 2020$181,000
-68.6%
79,573
-35.9%
0.00%
-100.0%
Q4 2019$577,000
+11.4%
124,230
-17.3%
0.00%0.0%
Q3 2019$518,000
+33.2%
150,193
+27.1%
0.00%
+100.0%
Q2 2019$389,000
-25.9%
118,161
-31.8%
0.00%
-50.0%
Q1 2019$525,000
+74.4%
173,164
+51.2%
0.00%
Q4 2018$301,000
+49.8%
114,539
+91.3%
0.00%
Q3 2018$201,000
+673.1%
59,884
+409.1%
0.00%
Q2 2018$26,0000.0%11,7630.0%0.00%
Q1 2018$26,000
-63.9%
11,763
-46.9%
0.00%
Q3 2017$72,000
-51.4%
22,147
-51.7%
0.00%
Q2 2017$148,000
-24.5%
45,864
-35.7%
0.00%
Q1 2017$196,000
+575.9%
71,378
+471.0%
0.00%
Q4 2016$29,000
+7.4%
12,500
-17.8%
0.00%
Q3 2016$27,00015,2000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders